USANA HEALTH SCIENCES INC (USNA) Stock Price & Overview

NYSE:USNAUS90328M1071

Current stock price

16.91 USD
-0.23 (-1.34%)
At close:
16.91 USD
0 (0%)
After Hours:

The current stock price of USNA is 16.91 USD. Today USNA is down by -1.34%. In the past month the price decreased by -21.97%. In the past year, price decreased by -38.08%.

USNA Key Statistics

52-Week Range16.715 - 38.32
Current USNA stock price positioned within its 52-week range.
1-Month Range16.715 - 22.19
Current USNA stock price positioned within its 1-month range.
Market Cap
309.115M
P/E
8.81
Fwd P/E
8.29
EPS (TTM)
1.92
Dividend Yield
N/A

USNA Stock Performance

Today
-1.34%
1 Week
-2.48%
1 Month
-21.97%
3 Months
-15.11%
Longer-term
6 Months -43.14%
1 Year -38.08%
2 Years -65.13%
3 Years -73.12%
5 Years -82.67%
10 Years -72.15%

USNA Stock Chart

USANA HEALTH SCIENCES INC / USNA Daily stock chart

USNA Technical Analysis

ChartMill assigns a technical rating of 0 / 10 to USNA. When comparing the yearly performance of all stocks, USNA is a bad performer in the overall market: 86.53% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

USNA Fundamental Analysis

ChartMill assigns a fundamental rating of 5 / 10 to USNA. While USNA has a great health rating, its profitability is only average at the moment.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

USNA Earnings

On February 17, 2026 USNA reported an EPS of 0.6 and a revenue of 226.20M. The company beat EPS expectations (43.47% surprise) and missed revenue expectations (-1.86% surprise).

Next Earnings DateApr 20, 2026
Last Earnings DateFeb 17, 2026
PeriodQ4 / 2025
EPS Reported$0.60
Revenue Reported226.2M
EPS Surprise 43.47%
Revenue Surprise -1.86%

USNA Forecast & Estimates

6 analysts have analysed USNA and the average price target is 39.78 USD. This implies a price increase of 135.25% is expected in the next year compared to the current price of 16.91.

For the next year, analysts expect an EPS growth of 6.25% and a revenue growth 1.88% for USNA


Analysts
Analysts43.33
Price Target39.78 (135.25%)
EPS Next Y6.25%
Revenue Next Year1.88%

USNA Groups

Sector & Classification

USNA Financial Highlights

Over the last trailing twelve months USNA reported a non-GAAP Earnings per Share(EPS) of 1.92. The EPS decreased by -26.15% compared to the year before.


Income Statements
Revenue(TTM)925.26M
Net Income(TTM)16.99M
Industry RankSector Rank
PM (TTM) 1.86%
ROA 2.34%
ROE 3.22%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%-6.25%
Sales Q2Q%5.89%
EPS 1Y (TTM)-26.15%
Revenue 1Y (TTM)8.28%

USNA Ownership

Ownership
Inst Owners58.34%
Shares18.28M
Float10.37M
Ins Owners0.65%
Short Float %3.88%
Short Ratio3.07

About USNA

Company Profile

USNA logo image USANA Health Sciences, Inc. develops and manufactures nutritional, personal care and weight-management products. The company is headquartered in Salt Lake City, Utah and currently employs 1,570 full-time employees. Its segments include Direct selling and Hiya direct-to-consumer. The Direct Selling segment develops and manufactures science-based nutritional, personal care and skincare products with a primary focus on promoting long-term health and wellness in various geographic markets worldwide that are distributed through the direct selling channel. The Hiya direct-to-consumer segment is a provider of children’s health and wellness products in the United States that are distributed through the direct-to-consumer channel. Its product line includes USANA Nutritionals Optimizers, Essentials/CellSentials, and Foods. USANA Nutritionals Optimizers products include Proflavanol, CoQuinone 30, and BiOmega-3. Essentials/CellSentials products include USANA CellSentials and HealthPak 100.

Company Info

IPO: 1993-10-28

USANA HEALTH SCIENCES INC

3838 West Parkway Blvd.

Salt Lake City UTAH 84120 US

CEO: Kevin G. Guest

Employees: 1570

USNA Company Website

USNA Investor Relations

Phone: 18019547100

USANA HEALTH SCIENCES INC / USNA FAQ

What does USNA do?

USANA Health Sciences, Inc. develops and manufactures nutritional, personal care and weight-management products. The company is headquartered in Salt Lake City, Utah and currently employs 1,570 full-time employees. Its segments include Direct selling and Hiya direct-to-consumer. The Direct Selling segment develops and manufactures science-based nutritional, personal care and skincare products with a primary focus on promoting long-term health and wellness in various geographic markets worldwide that are distributed through the direct selling channel. The Hiya direct-to-consumer segment is a provider of children’s health and wellness products in the United States that are distributed through the direct-to-consumer channel. Its product line includes USANA Nutritionals Optimizers, Essentials/CellSentials, and Foods. USANA Nutritionals Optimizers products include Proflavanol, CoQuinone 30, and BiOmega-3. Essentials/CellSentials products include USANA CellSentials and HealthPak 100.


Can you provide the latest stock price for USANA HEALTH SCIENCES INC?

The current stock price of USNA is 16.91 USD. The price decreased by -1.34% in the last trading session.


What is the dividend status of USANA HEALTH SCIENCES INC?

USNA does not pay a dividend.


How is the ChartMill rating for USANA HEALTH SCIENCES INC?

USNA has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 5 out of 10.


Is USANA HEALTH SCIENCES INC (USNA) stock a good buy?

This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on USNA.


Can you provide the market cap for USANA HEALTH SCIENCES INC?

USANA HEALTH SCIENCES INC (USNA) has a market capitalization of 309.11M USD. This makes USNA a Small Cap stock.


Can you provide the ownership details for USNA stock?

You can find the ownership structure of USANA HEALTH SCIENCES INC (USNA) on the Ownership tab.